This glass is 70% more resistant to scratches and falls.
Read more
This Glass Won’t Scratch
Posted in futurism
Let’s face it: Tablets are on the brink of death, and it’s difficult to get excited about a new slate these days. And even though tablet-laptop hybrids are taking off, that market is cornered by Surfaces and iPad Pros. So I wasn’t prepared to be as thrilled as I was by Lenovo’s latest offering. The Yoga Book, based on my experience with a preview unit, is not merely a mimicry of Microsoft’s Surface Book; it has impressively innovative features and a well-thought-out interface that make it a solid hybrid in its own right.
Read more
Maker Faire 2016: Roy The Robot
Posted in robotics/AI
Luv this article because it hits a very important topic of how will things change with BMI/ mind control technology in general. For example with BMI will we need wearable devices? if so, what type and why? Also, how will banking, healthcare, businesses, hospitality, transportation, media and entertainment, communications, government, etc. in general will change with BMI and AI together? And, don’t forget cell circuitry, and DNA storage and processing capabilities that have been proven to date and advancing.
When you take into account what we are doing with synthetic biology, BMI, AI, and QC; we are definitely going to see some very amazing things just within the next 10 years alone.
Neuroscientists have just demonstrated that we can control drones with our minds. Find out how this shapes the future of digital marketing.
A very old story and one that myself and others have raised many times. However, worth repeating due to the current advancements in BMI.
A vulnerability of brain implants to cyber-security attacks could make “brainjacking”, which has been discussed in science fiction for decades, a reality, say researchers from the University of Oxford. Writing in The Conversation, an Australia-based non-profit media, Laurie Pycroft discussed brain implants as a new frontier of security threat.
The most common type of brain implant is the deep brain stimulation (DBS) system. It consists of implanted electrodes positioned deep inside the brain connected to wires running under the skin, which carry signals from an implanted stimulator.
The stimulator consists of a battery, a small processor, and a wireless communication antenna that allows doctors to programme it. In essence, it functions much like a cardiac pacemaker, with the main distinction being that it directly interfaces with the brain, Pycroft explained.
Nice.
DARPA-supported researchers have developed a new approach for synthesizing ultrathin materials at room temperature—a breakthrough over industrial approaches that have demanded temperatures of 800 degrees Celsius or more. The advance opens a path to creating a host of previously unattainable thin-film microelectronics, whose production by conventional methods has been impossible because many components lose their critical functions when subjected to high temperatures.
The new method, known as electron-enhanced atomic layer deposition (EE-ALD), was recently developed at the University of Colorado, Boulder (CU) as part of DARPA’s Local Control of Materials Synthesis (LoCo) program. The CU team demonstrated room-temperature deposition of silicon and gallium nitride—linchpin elements in many advanced microelectronics—as well as the ability to controllably etch specific materials, leading to precise spatial control in three dimensions. Such a capability is critical as the demand grows for ever-smaller device architectures.
After first demonstrating the process in early 2015, team members went on to perform detailed mechanistic studies to learn how best to exploit and control EE-ALD for film growth. By controlling the electron energy during the ALD cycles, they discovered that they could tune the process to favor either material deposition or removal. The ability to selectively remove (etch) deposited material with electrons under conditions as low as room temperature is unprecedented and is anticipated to enhance film quality. The group is also exploring other methods to etch specific materials—such as aluminum nitride and hafnium oxide, important in specialized electronics applications—showing that they can selectively etch these materials in composites, which provides an attractive alternative to traditional masking approaches.
Read more
Never under estimate people you never know who may be the next Bill Gates.
After losing his left arm to cancer in 2008, Jonny Matheny’s life changed radically. The self-styled West Virginia hillbilly, formerly a retail bread sales and delivery man, started traveling to medical research facilities around the country to volunteer as a test-subject for advanced prosthetics and experimental surgeries. Today, Matheny is something of a Model T for cyborgs, wielding one of the most advanced mind-controlled prosthetics ever built.
When I met Matheny at a DARPA technology expo earlier this year, I was astounded by the flexibility and responsiveness of his Modular Prosthetic Limb, the latest in a series of mind-controlled prosthetics developed at the Johns Hopkins Applied Physics Laboratory. But nothing drives home the revolutionary potential of a device like this than seeing it used to perform mundane tasks: effortlessly putting on a hat or stirring a pot, for instance.
A new video by Freethink gives us a behind-the-scenes look at Matheny’s journey to become the world’s most sophisticated bionic man. Honestly, more than reading any detailed scientific primer, watching a guy serve salad with a carbon-fiber arm that takes cues from his brain convinced me that the future is going be full of cyborgs, and that the rest of us will be be jealous.
Read more
Interesting perspective on cancer.
A lot of the focus in the medical approach to cancer focuses on destroying it, but what if it was treated cancer like long-term diseases such as diabetes? Researchers have explored the concept of a method to control cancer with a drug delivery system that keeps the cells from multiplying.
The method, which researchers have called the “metronomic dosage regimen,” involves giving the patient lower doses of chemotherapy more frequently to create an environment where cancer cells cannot grow.
“This new system takes some existing cancer therapy drugs for ovarian cancer, delivers both of them at the same time and allows them to work synergistically,” said Adam Alani, an associate professor in the Oregon State University/Oregon Health & Science University College of Pharmacy, and lead author on the study published in the journal Chemistry of Materials. “Imagine if we could manage cancer on a long-term basis as a chronic condition, like we now do high blood pressure or diabetes. This could be a huge leap forward.”